Desmethylsibutramine
Desmethylsibutramine is a chemical compound that is structurally related to sibutramine, a drug that was previously used as an appetite suppressant for the treatment of obesity. Desmethylsibutramine is one of the primary active metabolites of sibutramine, which means it is formed in the body when sibutramine is metabolized.
Chemical Structure and Properties[edit | edit source]
Desmethylsibutramine belongs to the class of compounds known as phenethylamines. Its chemical structure is similar to that of sibutramine, with the primary difference being the absence of a methyl group. This structural modification results in different pharmacological properties compared to the parent compound.
Pharmacology[edit | edit source]
Desmethylsibutramine acts as a serotonin-norepinephrine reuptake inhibitor (SNRI). This means it inhibits the reuptake of the neurotransmitters serotonin and norepinephrine, leading to increased levels of these chemicals in the brain. This mechanism is believed to contribute to its appetite-suppressing effects.
Medical Use[edit | edit source]
While sibutramine was approved for medical use in the treatment of obesity, desmethylsibutramine itself is not approved as a medication. Sibutramine was withdrawn from the market in many countries due to concerns about its cardiovascular safety profile, including increased risks of heart attack and stroke.
Legal Status[edit | edit source]
Due to its structural similarity to sibutramine and its potential for similar effects, desmethylsibutramine is often regulated under the same legal frameworks as sibutramine. In many jurisdictions, it is classified as a controlled substance, making its manufacture, distribution, and possession subject to legal restrictions.
Safety and Side Effects[edit | edit source]
The safety profile of desmethylsibutramine is not well-documented, but it is likely to share similar side effects with sibutramine. These may include increased heart rate, elevated blood pressure, dry mouth, constipation, and insomnia. Due to the potential for serious cardiovascular side effects, the use of desmethylsibutramine is not recommended.
See Also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
